Pharma

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The Zitelman Group announced it has led a $600,000 Series B Preferred equity round for Israel-based medical device firm, Flexicath, Ltd. Flexicath received a 510(k) clearance from FDA in October, allowing it to place its FirmGrip sterile catheter intravenous (IV) system in the U.S market. The funding will be used to ramp-up U.S. and international sales and marketing for the FirmGrip catheter.


Today in Drug/Product Approvals...keeping you current

FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09

Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09

Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09